title: [EGFR inhibition in NSCLC tumor cell lines : Influence on cell cycle and tumor control].
authors.affiliation: Strahlenklinik, Strahlenimmunbiologie, Universitätsklinikum Erlangen, Universitätsstraße 27, 91054, Erlangen, Deutschland. udo.gaipl@uk-erlangen.de.
authors.forename: Udo S
authors.initials: US
authors.lastname: Gaipl
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D066246:ErbB Receptors / Q000378:metabolism*; D059585:G1 Phase Cell Cycle Checkpoints / Q000187:drug effects* / Q000528:radiation effects; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000532:radiotherapy; D011836:Radiation Tolerance / Q000187:drug effects* / Q000528:radiation effects; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; C512478:EGFR protein, human; D066246:ErbB Receptors